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The cis-acting replication element 
of the Hepatitis C virus genome 
recruits host factors that influence 
viral replication and translation
Pablo Ríos-Marco, Cristina Romero-López & Alfredo Berzal-Herranz
The cis-acting replication element (CRE) of the hepatitis C virus (HCV) RNA genome is a region of 
conserved sequence and structure at the 3′ end of the open reading frame. It participates in a complex 
and dynamic RNA-RNA interaction network involving, among others, essential functional domains 
of the 3′ untranslated region and the internal ribosome entry site located at the 5′ terminus of the 
viral genome. A proper balance between all these contacts is critical for the control of viral replication 
and translation, and is likely dependent on host factors. Proteomic analyses identified a collection 
of proteins from a hepatoma cell line as CRE-interacting candidates. A large fraction of these were 
RNA-binding proteins sharing highly conserved RNA recognition motifs. The vast majority of these 
proteins were validated by bioinformatics tools that consider RNA-protein secondary structure. 
Further characterization of representative proteins indicated that hnRNPA1 and HMGB1 exerted 
negative effects on viral replication in a subgenomic HCV replication system. Furthermore DDX5 and 
PARP1 knockdown reduced the HCV IRES activity, suggesting an involvement of these proteins in HCV 
translation. The identification of all these host factors provides new clues regarding the function of the 
CRE during viral cycle progression.
Hepatitis C virus (HCV) infection is controlled by a number of host and viral factors (RNA and proteins) that 
cooperate to initiate the different steps of the viral cycle. The use of secondary and tertiary, structurally conserved, 
functional genomic RNA elements capable of interacting with proteins and other RNA domains affords impor-
tant advantages in terms of propagation efficiency. These genomic RNA elements direct and regulate translation, 
replication and encapsidation. The HCV genome is a single stranded, positive RNA molecule of ~9.6 kb that codes 
for a single open reading frame (ORF), flanked by untranslated regions (5′ and 3′ UTR) of conserved sequence 
and structure1,2. These regions play essential roles in the progress of the viral cycle.
HCV protein synthesis initiation is guided by a subset of regulatory structural RNA elements that define an 
internal ribosome entry site (IRES)3,4, mostly located at the 5′ UTR. The IRES operates via a different mechanism 
to that used by most cellular mRNAs. HCV protein accumulation determines the initiation of the replication 
process mediated by the 3′ UTR5–7. This region contains RNA domains of conserved sequence and structure6,8 that 
are specifically recognized by viral RNA-dependent RNA polymerase NS5B9 and other host and viral factors10–13. 
Further, the 3′ UTR acts as an enhancer of IRES function in hepatic cell lines14–16 .
Other structurally and evolutionarily conserved RNA motifs distinct from those in the UTRs have been 
reported to act as cis signals that modulate essential steps during the viral cycle17–19. Among these, the HCV 
cis-acting replication element (CRE), located within the 3′ end of the ORF, consists of three stem-loops: 5BSL3.1, 
5BSL3.2 and 5BSL3.3 (Fig. 1a). The establishment of long range RNA-RNA interactions between the 5BSL3.2 
and 3′ SLII within the 3′ UTR, or the Alt sequence upstream of the CRE, is critical for the efficient synthesis of the 
viral RNA negative strand20,21. Importantly, the existence of an additional, direct, long-range RNA-RNA contact 
involving the stem-loop 5BSL3.2 and the essential subdomain IIId of the IRES element has been shown to exert 
an inhibitory effect on HCV IRES function even in the presence of the enhancer 3′ UTR22. Thus, a dynamic and 
complex network of RNA-RNA contacts coordinated by the CRE 5BSL3.2 domain is established throughout the 
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HCV genome. The establishment of a specific interaction may depend on the binding of host and viral proteins, 
which would also help to bring both ends of the HCV genome into close proximity, favoring the acquisition of a 
circular topology. Numerous factors have been described to simultaneously interact with the 5′ and the 3′ UTR 
of the viral RNA12,13,23, but little is known about the role of CRE in the recruitment of cellular proteins24. Given 
the involvement of the CRE in both viral translation and replication, it seems likely that host factors previously 
shown to influence these processes also associate with the CRE to promote or stabilize different RNA-RNA con-
tacts. Indeed, the CRE could act as a natural decoy, sequestering or limiting the amounts of certain proteins, thus 
inhibiting or promoting different steps of the viral cycle and the transitions between them.
The present work provides evidence that the CRE associates with a collection of cellular proteins, most of 
them reported here for first time, which allows them to connect with the HCV genome. The identification of 
these proteins by liquid chromatography coupled to mass spectrometry (LC-MS/MS) showed that the CRE is 
pulled down with a pool of proteins with different biological functions, some of them previously identified as 
IRES- or 3′ UTR-interacting proteins. Many of these proteins bear RNA-recognition motifs (RRMs) within their 
Figure 1. HCV CRE structure and pull-down strategy. (A) HCV genome sequence corresponding to 
the C + HV fragment containing the CRE structure and the downstream region for the hybridization 
of the oligonucleotide used in the pull-down experiments (red). (B) Proteomic method for identifying 
CRE-interacting candidates. Binding reactions between Huh-7 S10 lysates and CRE were incubated in the 
presence of streptavidin-coated magnetic beads (Dynabeads) and pulled-down. Some 1/3 of the sample was 
subjected to SDS-PAGE and the protein stained. Line 1: control samples corresponding to CRE linked to non-
biotinylated asHCV-9414; Line 2: positive samples corresponding to CRE linked to biotinylated asHCV-9414 
(b-asHCV-9414). Some 2/3 of the samples were digested, analyzed by LC-MS/MS, and compared two by two as 
explained in Methods.
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sequences. Additionally, in silico binding predictions suggested that subdomain 5BSL3.2 plays a role in the pro-
teins recruitment. Via knockdown experiments it was confirmed that protein heterogeneous nuclear ribonucleo-
protein A1 (hnRNPA1) and High Mobility Group Box 1 (HMGB1) exert biological effects on viral replication 
whereas DEAD box protein 5 (DDX5) and Poly [ADP ribose] polymerase 1 (PARP1) play a role in HCV transla-
tion. Given the involvement of these proteins in different pathways of cell metabolism, the present results support 
the idea that CRE plays a biological function in the viral cycle by interacting with the host factors here identified. 
This work provides the first evidence of association of a pool of host cell factors with HCV genome through CRE 
and the involvement of some of them in different stages of the HCV cycle.
Results
Identification of cellular proteins that associate with CRE. To identify eukaryotic proteins able to 
interact with the HCV CRE, pull-down assays were performed involving CRE and Huh-7 cell lysates. To this end, 
a genomic HCV RNA fragment comprising the CRE plus the downstream hypervariable region (9181–9414) 
was transcribed (Fig. 1A). This RNA fragment allows the stem loop conformation of the CRE subdomains, and 
can be annealed to a biotinylated oligonucleotide at its 3′ end, thus allowing fragment capture by affinity chro-
matography (Fig. 1A). As a control sample the same RNA molecule was annealed to a non-biotinylated oligonu-
cleotide with the same sequence. The non-biotinylated oligonucleotyde control strategy has already been used by 
other authors for LC-MS/MS analysis of RNA-protein complexes in the HCV related Japanese Encephalitis Virus, 
confirming the suitability of this control25. S10 lysates were obtained as described in Methods and incubated 
with the RNA fragment in the presence of streptavidin-coupled electromagnetic beads (Dynabeads) that interact 
specifically with biotin-containing molecules. To avoid recovering proteins with low binding stability, reactions 
were performed at low ion concentrations and performing washes under stringent conditions. After washing and 
elution, some 1/3 of the samples were subjected to SDS-PAGE (Fig.1b). As expected, efficient protein enrichment 
(compared to the control) was seen for the samples with biotinylated oligonucleotides (Fig. 1B).
To identify the pool of proteins, pull-downs were subjected to trypsin digestion and LC-MS/MS. Biological 
replicates were compared two by two using PEAKS software, and the proteins enriched in at least three of the four 
replicates selected (see Methods). As shown in Table 1, more than 50 proteins pulled-down with CRE were iden-
tified. In most of the proteins, at least 80% of detected peptides were unique; LC-MS/MS therefore provided very 
good discrimination. Interestingly, some of these proteins, such as XRCC6, hnRNPA1 and DDX5, have already 
been proposed to interact with other HCV genome regions and/or proteins12,24,26.
Functional classification of pulled-down proteins. The candidates that interact with CRE were classi-
fied using the Panther Classification System gene list analysis tool. Figure 2A shows the CRE-pulled-down pro-
tein classification based on “molecular function” criteria. The most represented gene ontology (GO) terms were 
Figure 2. Classification of CRE-interacting protein candidates. (A) Panther pie-chart showing the 
classification of the 55 proteins identified in terms of their molecular function. The two main GO terms were 
subclassified under the same criterion (pie charts on the right). GO term codes are shown in brackets. (B) 
Classification of RNA-binding proteins via search of the RBPDB database, represented in terms of the number 
of RRMs. Protein names correspond to the gene names shown in Table 1.
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Protein name Name Accession M P U.P Cov. Ratio HCV gen. Ref.
40S ribosomal protein SA (Fragment) RPSA C9J9K3 30 3 3 15.00 1.00 : 0.35 IRES 61
Actin. cytoplasmic 1 ACTB P60709 42 21 4 40.18 1.00 : 0.34
Activated RNA polymerase II transcriptional coactivator p15 SUB1 P53999 14 10 10 43.31 1.00 : 0.02 3′ UTR 26
Alpha-enolase ENO1 P06733 47 6 4 16.53 1.00 : 0.06
AT-rich interactive domain-containing protein 3A ARID3A Q99856 63 9 8 14.45 1.00 : 0.20
Bifunctional polynucleotide phosphatase/kinase PNKP Q96T60 57 22 19 38.10 1.00 : 0.01
Cellular nucleic acid-binding protein (isoform 2) CNBP P62633-2 19 7 6 35.68 1.00 : 0.04
DAZ-associated protein 1 DAZPA1 Q96EP5 43 6 5 18.42 1.00 : 0.05
DNA ligase 3 LIG3 P49916 113 17 13 16.60 1.00 : 0.04
DNA polymerase beta POLB P06746 38 8 7 24.25 1.00 : 0.01 3′ UTR 26
DNA repair protein XRCC1 XRCC1 P18887 69 20 17 24.76 1.00 : 0.02
DNA-(apurinic or apyrimidinic site) lyase APEX1 P27695 36 5 4 19.81 1.00 : 0.00
Embryonic stem cell-specific 5-hydroxymethylcytosine-binding protein HMCES Q96FZ2 41 9 9 27.68 1.00 : 0.03
Eukaryotic translation initiation factor 3 subunit I EIF3I Q13347 37 5 4 17.00 1.00 : 0.21
Exosome complex component RRP41 EXOSC4 Q9NPD3 26 5 4 20.91 1.00 : 0.04
Far upstream element-binding protein 3 FUBP3 Q96I24 62 7 6 14.90 1.00 : 0.28
Fructose-bisphosphate aldolase A ALDOA P04075 39 7 6 18.04 1.00 : 0.11
Glyceraldehyde-3-phosphate dehydrogenase GAPDH P04406 36 9 8 23.78 1.00 : 0.05 3′ UTR 26
Helicase-like transcription factor HLTF Q14527 114 27 25 22.94 1.00 : 0.04
Heterogeneous nuclear ribonucleoprotein A/B HNRNPAB D6RD18 30 5 4 21.27 1.00 : 0.02
Heterogeneous nuclear ribonucleoprotein A0 HNRNPA0 Q13151 31 9 8 26.88 1.00 : 0.03 IRES 61
Heterogeneous nuclear ribonucleoprotein A1 HNRNPA1 F8W6I7 33 30 16 53.58 1.00 : 0.03 3′ UTR IRES 26 48 61
Heterogeneous nuclear ribonucleoprotein A3 HNRNPA3 P51991 40 19 17 34.92 1.00 : 0.02
Heterogeneous nuclear ribonucleoprotein D-like (isoform 3) HNRNPDL O14979-3 28 5 4 22.75 1.00 : 0.06 3′ UTR IRES 26 61
Heterogeneous nuclear ribonucleoprotein M (isoform 2) HNRNPM P52272-2 74 65 14 50.28 1.00 : 0.11
Heterogeneous nuclear ribonucleoprotein U HNRNPU Q00839 91 24 21 21.72 1.00 : 0.08 3′ UTR 26
Heterogeneous nuclear ribonucleoproteins A2/B1 HNRNPA2B1 P22626 37 20 17 39.94 1.00 : 0.04
High mobility group protein B1 HMGB1 P09429 25 9 5 36.51 1.00 : 0.01 IRES 61
High mobility group protein B2 HMGB2 P26583 24 14 11 41.63 1.00 : 0.02
Isocitrate dehydrogenase [NADP] cytoplasmic IDH1 O75874 47 19 16 39.37 1.00 : 0.27
Lamina-associated polypeptide 2. isoform alpha TMPO P42166 75 9 6 16.85 1.00 : 0.08
L-lactate dehydrogenase A chain LDHA P00338 37 11 9 31.70 1.00 : 0.18
Poly [ADP-ribose] polymerase 1 PARP1 P09874 113 53 51 36.61 1.00 : 0.02 3′ UTR 26
Probable ATP-dependent RNA helicase DDX5 DDX5 P17844 69 8 6 15.06 1.00 : 0.30 3′ UTR 26
Proteasome subunit alpha type-1 PSMA1 P25786 30 4 3 18.72 1.00 : 0.14
Putative RNA-binding protein 3 RBM3 P98179 17 7 7 36.94 1.00 : 0.04 IRES 61
Ras GTPase-activating protein-binding protein 1 G3BP1 Q13283 52 13 12 26.10 1.00 : 0.31
Ras GTPase-activating protein-binding protein 2 (isoform B) G3BP2 Q9UN86-2 51 10 9 17.87 1.00 : 0.11
Replication protein A 14 kDa subunit RPA3 P35244 14 3 3 31.33 1.00 : 0.02
Replication protein A 32 kDa subunit (isoform 3) RPA2 P15927-3 39 6 5 16.11 1.00 : 0.00
Replication protein A 70 kDa DNA-binding subunit RPA1 P27694 68 24 19 31.69 1.00 : 0.02
RNA-binding motif. single-stranded-interacting protein 1 RBMS1 E7ETU5 46 5 5 16.80 1.00 : 0.05
RNA-binding protein 7 RBM7 Q9Y580 31 5 4 17.01 1.00 : 0.02
RNA-binding protein Musashi homolog 1 MSI1 O43347 39 7 5 18.32 1.00 : 0.04
RNA-binding protein Musashi homolog 2 (isoform 2) MSI2 Q96DH6-2 28 11 8 34.66 1.00 : 0.04 IRES 61
Single-stranded DNA-binding protein (Fragment) SSBP1 E7EUY5 16 3 3 27.74 1.00 : 0.14 IRES 61
Splicing factor. proline- and glutamine-rich SFPQ P23246 76 14 13 19.48 1.00 : 0.29 3′ UTR 26
T-complex protein 1 subunit theta CCT8 P50990 60 13 12 25.59 1.00 : 0.25
Thymidylate kinase DTYMK P23919 24 7 4 30.50 1.00 : 0.02
Transcriptional activator protein Pur-beta PURB Q96QR8 33 5 4 16.26 1.00 : 0.04
X-ray repair cross-complementing protein 5 XRCC5 P13010 83 24 22 26.74 1.00 : 0.15
X-ray repair cross-complementing protein 6 XRCC6 P12956 70 29 28 35.22 1.00 : 0.15 3′ UTR IRES 26 61
YTH domain family protein 1 YTHDF1 Q9BYJ9 61 14 5 25.51 1.00 : 0.09
YTH domain family protein 2 YTHDF2 Q9Y5A9 62 14 10 25.82 1.00 : 0.11
YTH domain family protein 3 YTHDF3 Q7Z739 64 18 7 32.88 1.00 : 0.10
Table 1.  LC-MS/MS identification of proteins pulled-down with HCV CRE. Name, gene name; Accession, 
Uniprot accession number; M, molecular mass (kDa); P, number of peptides identified in the positive samples; 
U.P, number of unique peptides identified in the positive samples; Cov., coverage of full-length protein in 
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“binding” (GO:0005488) (42.1%) and “catalytic activity” (34.2%). As expected, the majority of proteins classified 
as “binding” were “nucleic acid binding” proteins (GO:003676) (79.5% of the binding group); proteins capable of 
entering a stable union with CRE were therefore enriched. In addition, a large number of proteins with catalytic 
activities was seen, with transferases and helicases the most strongly represented. Thus, we can hypothesize a pos-
sible biological function for either group of proteins in the viral cycle, mediated by their association with the CRE.
An additional classification tool with a broader and both functional and structural focus was used. DAVID 
bioinformatics resources can extract biological features/meanings associated with large gene lists by simultane-
ously comparing terms from different annotation categories27. The DAVID Clustering Annotation tool revealed 
eight significant protein clusters for the whole group of pulled-down host factors (Table 2). The cluster with the 
highest enrichment score (15.9) was composed of terms related to RNA binding motifs and domains; all had 
very high significance values. Among the proteins clustered as RNA binding proteins were several heterogeneous 
nuclear ribonucleoproteins (hnRNPs), Ras-GTPase activating-binding proteins (G3BPs) and splicing factors.
All the proteins belonging to the RNA-binding cluster were checked against the RNA-Binding Protein 
(RBPDB) database (http://rbpdb.ccbr.utoronto.ca/) to identify the type and number of RNA binding domains 
involved in the protein-CRE interaction. Interestingly, all showed the presence of RRMs in their sequence 
(Fig. 2B). The presence of just one RRM seems sufficient to allow pulldown with CRE, as seen for G3BP1 G3BP2, 
RBM3 and RBM7. Several hnRNPs showed two RRMs in their sequence, but only the hnRNPM protein had 
more than two RRMs. To search for similarities between RRMs, all 29 protein sequences corresponding to these 
domains were compared, and two highly conserved regions found (Fig. 3). Together, these data suggest that there 
is a large group of the pulled-down proteins (29 out of the 55) that contain conserved RRMs.
In silico interaction of RNA- and DNA-binding proteins with CRE. To further study the associations 
detected by LC-MS/MS, an in silico interaction study was performed, introducing the CRE sequence to the human 
RNA- and DNA-binding proteome. catRAPID tools estimate the binding propensity of a protein-RNA pair using 
an algorithm that considers protein and RNA secondary structure, hydrogen bonding, and contribution of van 
der Waals forces28. The CRE nucleotide sequence was compared against the Homo sapiens proteome using the 
catRAPID omics tool, searching for interacting RNA- and DNA-binding proteins. Interestingly, 71% (39/55) of 
the proteins identified in the pull-down experiments were predicted to bind as well to the CRE sequence (Fig. 4). 
In addition, among these 39 proteins, 30% fit within the upper quartile score, indicating a good reliability on the 
identification. The in silico binding prediction is in agreement with the pull-down results and reinforces these 
proteins as CRE-associated factors.
Deeper mapping of the binding sites of the CRE-interacting proteins was performed using nine representa-
tive factors detected in both in silico and the pull-down experiments. The selected proteins were analyzed using 
the catRAPID graphics tool, comparing each candidate protein’s whole sequence against the C + HV sequence 
transcript. Figure 5 shows the aminoacid-nucleotide interaction heat-map for each protein against the CRE. 
Remarkably, all the proteins examined showed very similar CRE interaction patterns. The majority of the proteins 
most strongly interacted with the region comprising nucleotides 9280–9330. This region includes the 5BSL3.2 
apical loop and the 5′ end of 5BSL3.3. In contrast, the nucleotides downstream of the CRE have no apparent role 
in these interactions; their catRAPID scores were low. This indicates that, in the C + HV fragment, nucleotides 
mainly belonging to the CRE show protein binding functionality. It should be noted that, for the RNA-binding 
proteins, the interacting aminoacids clearly belonged to their RRMs. For instance, hnRNPA1 (RRMs at 14–97 and 
105–184) showed its strongest interaction within the first 200 aminoacids. In addition, hnRNPM showed strong 
overlapping between its RRMs and the interacting regions, especially at its third RRM (653–729). This was the 
case too for the second RRM of MSI1 (109–186) and both the RRMs of the hnRNPDL (148–230 and 233–312). 
Together, these findings suggest a clear involvement of CRE 5BSL3.2 and 5BSL3.3 in CRE-protein association, 
mediated by RRMs in the case of the RNA-binding proteins.
Effect of gene modulation on HCV replication. To study the potential effect of these proteins in the 
viral replication, gene silencing assays were performed. Six proteins were selected based on previously suggested 
HCV interactions or a possible role in the viral cycle, and knockdown experiments performed on them. To this 
end, a cell line carrying a stable HCV subgenomic replicon (Huh-7 NS3-3′ ) was transfected with siRNAs designed 
against the mRNA of these proteins. For this purpose those siRNA sequences that have already been proved to 
be effective were used29–31. The specific effect of each siRNA was confirmed by immunoblotting (Fig. 6A). As can 
be seen, all the siRNAs reduced their target protein levels (from 40% to 70%) without significantly affecting any 
of the other assayed proteins. RNA was extracted from cells treated with the different siRNAs and HCV replicon 
levels quantified by qRT-PCR (Fig. 6B). Interestingly, hnRNPA1 gene knockdown resulted in a two-fold increase 
in HCV replicon levels compared to those associated with a non-targeting siRNA. The same tendency, but with 
only a 1.5-fold increase, was observed in cells transfected with siHMGB1. No significant effect was detected for 
G3BP1, DDX5 and PARP1 knockdown compared to results obtained with non-targeting (NT) siRNA.
To confirm the knockdown results we selected hnRNPA1 and HMGB1 and cloned their respective coding 
genes into the pcDNA3 eukaryotic expression vector. Huh-7 cells were transfected with pcDNA3 (as a control) 
or the corresponding hnRNPA1- or HMGB1-pcDNA3 constructs. Interestingly, 48 h after transfection a signifi-
cant inhibition of the replicon levels was detected in both cases (Fig. 6C), reinforcing the results obtained in the 
positive samples by tryptic peptides (%); Ratio, average of peak area ratios from peptides in positive samples; 
compared to control samples; HCV gen., other reported HCV genome domains which associate with the 
protein; Ref., references for the named interactions.
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knockdown experiments for these two proteins. These results suggest that hnRNPA1 and HMGB1 negatively 
regulate HCV replication.
Moreover, direct interaction of hnRNPA1 with CRE was assayed through an RNA-immunoprecipitation pro-
tocol (RIP). Results shown in Fig. 6D shows that CRE RNA fragment, but not a control RNA 667, was amplified 
in immunoprecipitated samples after RIP using an anti-hnRNPA1 antibody. This experiment confirms a direct 
interaction between hnRNPA1 and HCV CRE.
DDX5 and PARP1 knockdown reduce viral translation efficiency. Since CRE was been shown to 
long-range interact with the IRES and inhibit its translation function22, an RNA construct containing a luciferase 
reporter gene was generated (ICU), to perform translation assays in knock down cells. This molecule contains the 
HCV IRES linked to the CRE and 3′ UTR through the Firefly luciferase gene 22 (Fig. 7A). After protein knockdown 
with the specific siRNAs, Huh-7 cells were transfected with the RNA construct, (Fig. 7A), and luciferase activity 
measured. The luciferase sequence of ICU includes its own stop codon, ensuring the correct translation of the 
reporter protein. A non-related transcript with a cap structure, containing Renilla luciferase reporter (cap-RLuc) 
was used for normalization of translation data. Translation efficiency at 4 h post-transfection is shown in Fig. 7B. 
Knockdown of DDX5 and PARP1 showed nearly of 40% of inhibition of HCV IRES activity. This effect was pres-
ent, but patently lower, in siHMGB1 treated cells. All these data indicate that DDX5 and PARP1 are required for 
full HCV IRES translation.
Discussion
Many processes are run by viral genomes through the use of structurally conserved functional RNA domains 
which form a dynamic, complex network of direct RNA-RNA interactions that may be regulated or stabilized by 
the recruitment of host or viral factors. In the case of HCV, the CRE region plays an active role in the organization 
of an RNA-RNA contact network involved in the regulation of viral translation and replication20–22,32,33.
ANNOTATION 
CLUSTER SCORE
ANNOTATION 
CATEGORY TERMS N P.VALUE BENJAMINI
Cluster 1 
15.9 INTERPRO RNA recognition motif, RNP-1 16 1.1E-16 1.4E-14
15.9 INTERPRO Nucleotide-binding, alpha-beta plait 16 1.3E-16 6.8E-15
15.9 SMART RRM 16 1.3E-16 2.2E-15
 Cluster 2 
8.87 GOTERM_BP_FAT DNA repair 14 2.7E-11 1.2E-8
8.87 GOTERM_BP_FAT response to DNA damage stimulus 14 8.0E-10 1.2E-7
8.87 GOTERM_BP_FAT cellular response to stress 14 1.2E-7 1.0E-5
 Cluster 3 
8.81 GOTERM_CC_FAT intracellular organelle lumen 24 1.0E-9 3.8E-8
8.81 GOTERM_CC_FAT organelle lumen 24 1.6E-9 4.6E-8
8.81 GOTERM_CC_FAT membrane-enclosed lumen 24 2.4E-9 5.4E-8
Cluster 4 
4.91 GOTERM_CC_FAT DNA replication factor A complex 4 7.0E-7 8.9E-6
4.91 GOTERM_CC_FAT replisome 4 1.3E-5 1.3E-4
4.91 GOTERM_CC_FAT nuclear replisome 4 1.3E-5 1.3E-4
4.91 GOTERM_CC_FAT nuclear replication fork 4 1.6E-5 1.3E-4
4.91 GOTERM_CC_FAT replication fork 4 1.6E-4 1.0E-3
Cluster 5 
3.71 GOTERM_BP_FAT RNA splicing 8 8.8E-5 3.6E-3
3.71 GOTERM_BP_FAT mRNA processing 8 1.9E-4 7.0E-3
3.71 GOTERM_BP_FAT mRNA metabolic process 8 4.4E-4 1.3E-2
Cluster 6 
3.57 GOTERM_BP_FAT RNA splicing, via transesterification reactions 6 2.7E-4 9.2E-3
3.57 GOTERM_BP_FAT RNA splicing, via transesterification reactions with bulged adenosine as nucleophile 6 2.7E-4 9.2E-3
3.57 GOTERM_BP_FAT nuclear mRNA splicing, via spliceosome 6 2.7E-4 9.2E-3
Cluster 7 
3.42 KEGG_PATHWAY Mismatch repair 4 2.0E-4 3.0E-3
3.42 KEGG_PATHWAY Homologous recombination 4 3.6E-4 3.7E-3
3.42 KEGG_PATHWAY DNA replication 4 7.6E-4 5.9E-3
Cluster 8 
3.3 GOTERM_BP_FAT nucleotide-excision repair, DNA damage removal 4 7.4E-5 3.3E-3
3.3 GOTERM_BP_FAT nucleotide-excision repair 4 1.2E-3 2.8E-2
3.3 GOTERM_BP_FAT DNA catabolic process 4 1.5E-3 3.3E-2
Table 2.  Functional annotation clustering of CRE-interacting candidates. SCORE, enrichment score of the 
annotation cluster; N, number of genes involved in the term.
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Figure 3. Alignment of RRMs corresponding to the RNA-binding proteins. All RRM sequences were 
obtained from the Uniprot database and proteins compared using DNAsis software. Complete homology 
between aminoacids is highlighted in yellow; strong homology is highlighted in green. There are two conserved 
regions within the first 60 aminoacids of the RRMs. The consensus sequence is represented below.
Figure 4. Match between experimental pulled-down proteins and in silico associations. Vein diagram 
showing the number of proteins identified in pull-down experiments and the catRAPID omics output. Of the 55 
pulled-down proteins, 39 were identified in silico to bind to the CRE sequence. These 39 proteins were ordered 
by their catRAPID omics Rating Star Score. Scores corresponding to quartile 2 (Q2) and quartile 2 (Q3) from 
the total of the in silico predicted proteins were used as a reference for the 39 coincident host factors.
www.nature.com/scientificreports/
8Scientific RepoRts | 6:25729 | DOI: 10.1038/srep25729
To our knowledge, very few attempts to study CRE-protein association have been made. The present work 
identifies a pool of 55 host proteins that are pulled-down by an RNA transcript corresponding to the HCV CRE. 
The majority of these proteins are proposed as HCV-interacting proteins for the first time. Using MALDI-MS, 
Oakland et al.24 identified six CRE-interacting proteins in 293T cells. Interestingly, two of these proteins were 
detected in the present study as well (hnRNPM and XRCC5), and another two (DDX17 and DDX3) are closely 
related to the reported RNA-helicase DDX5. In the present work, the resolving power of the LC-MS/MS system 
used not only allowed the identification of many more new proteins, it detected, with high coverage, a large num-
ber of unique peptides (Table 1). Moreover, label-free quantification using PEAKS software allowed the positive 
samples to be compared with the controls and discard any factors that were recovered in a non-specific manner, 
increasing the reliability of the results. The use of a non-biotinylated oligonucleotide as a control has been success-
fully used previously25 and it constitutes from our belief a good approach to discard unspecific targets.
As would be expected for an RNA-protein pull-down method, most of the proteins identified in this work 
were classified as nucleic acid binding proteins. This suggests direct association between them and the CRE. 
However, protein-mediated interactions cannot be ruled out since 6% of the factors were initially termed as 
protein-binding proteins. Using bioinformatics resources such as DAVID searches, which do not rely exclusively 
on GO terms, protein pool was clustered into eight different groups; that with highest score corresponded to 
RNA-binding proteins (Table 2). Interestingly, all this cluster′ s proteins shared the presence of one or more RRM, 
also termed RNA binding domains, within their sequences. The comparison of all RRMs showed two clear, highly 
conversed regions that matched consensus sequences previously defined as ribonucleoprotein domain RNP1 
and RNP2 (see consensus sequence in Fig. 3)34. The high degree of conservation in these sequences suggests they 
are involved in the association with the CRE. One example of this is the La protein, that interact with HCV IRES 
through its RRM and promote linkage between the 5′ and 3′ ends of the viral genome35.
The catRAPID algorithm, which studies RNA-protein interactions based on their sequences and secondary 
structure, strengthened the reliability of identification of the pulled-down proteins, even though some are termed 
DNA-binding proteins. HMGB1 provides an example of these proteins reported to bind with high affinity to 
branched RNA structures36. Another interesting feature of a group of proteins is their ability to bind AU-rich ele-
ments (AREs), The present work identified several proteins reported by other authors to act as ARE binding pro-
teins (ARE-BPs): hnRNPA137 DAZAP138, hnRNPA039, hnRNPA339,40 and RBM340. It is noteworthy that CRE has 
exposed AU-rich elements, i.e., the ARE consensus sequence (-AUUUA-) located in the apical loop of 5BSL3.1, 
and a non-canonical sequence in the apical loop of 5BSL3.2 (5′ -AUAUAU- 3′ ) (Fig. 1A). This would explain the 
abundance of recovered peptides corresponding to these proteins after LC-MS/MS.
Considering the involvement of CRE in HCV translation is interesting to remark that two proteins related to 
the regulation of translation were identified: RNA-helicase DDX5 and eukaryotic translation initiation factor I 
subunit I (eIF3I). In fact, other subunits such as eIF3E, eIF3F and eIF3H were also detected in one or two exper-
imental replicates, and other proteins related to translation (such as eIF1A, eIF2A and the 40S/60S ribosomal 
Figure 5. Heat-maps of aminoacid-nucleotide interactions. Nine proteins were subjected to interaction 
studies against the CRE sequence using the catRAPID graphics tool. Aminoacid-nucleotide interactions for the 
whole protein and RNA sequences are represented as heat-maps that show interacting score values between − 3 
and + 3. The strongest interacting regions correspond to the red areas; blue areas represent pairs showing weak 
aminoacid-nucleotide interaction. The CRE regions corresponding to nucleotides with high interaction values 
are highlighted in red in the chart on the right.
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Figure 6. Effect of mRNA knockdown in HCV replication. Replicon-containing cells (Huh-7-NS3-3′ ) 
were transfected with siRNAs directed against either hnRNPA1, DDX5, G3BP1, HMGB1 or PARP1, or with 
a non-targeting siRNA. After 48 h the cells were collected and RNA or protein extracted as described in 
Methods. (A) Protein lysates from Huh-7-NS3-3′ cells transfected with siRNA were resolved by SDS-PAGE and 
immunoblotted with specific antibodies for the assayed proteins or for a β -actin control. (B) RNA lysates were 
retrotranscribed and cDNA corresponding to HCV replicon amplified by qPCR. Changes in replicon levels were 
represented as fold changes normalized to GAPDH. Standard deviation is displayed for each siRNA. Significant 
differences between siRNAs and non-targeting siRNA are indicated above the corresponding bar (p < 0.05 
in a two-tailed Student’s t-test). (C) Overexpression of hnRNPA1 and HMGB1 coding genes. Replicon levels, 
normalized to GAPDH, are represented after 24 h and 48 h after transfection. P values indicating the statistical 
significance are included. Values are the mean of three independent experiments. A picture of a representative 
agarose gel showing the relative hnRNPA1 and HMGB1 mRNA levels to the GAPDH mRNA ones analyzed by 
RT-PCR is shown under each bar graph. (D) Immunoprecipitation of CRE and RNA 667 with anti-hnRNPA1 
antibody. After RIP, samples were subjected to RT-PCR and resolved in a 2% agarose gel. Immunoprecipitated 
(RIP) samples from cells transfected with CRE and RNA 667 were run in duplicates with a negative sample 
without template (− ). As positive controls, not immunoprecipitated lysates (L) and direct RNA template (T) 
were retrotranscribed and amplified. pUC19 plasmid digested with MspI was used as DNA size marker (M). 
Fragment sizes, in bp, are indicated on the left.
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proteins) were detected in previous pull-down experiments performed under less stringent conditions (data not 
shown). This is in good agreement with the HCV IRES translation regulation exerted by CRE22. The transla-
tion efficiency assays performed in this work show a clear involvement of DDX5 in HCV translation. DDX5 
knockdown up to a 40% was able to cause a specific decrease of IRES activity of 40% (Fig. 6B). However, this 
effect was not caused by other siRNAs assays that displayed even higher knockdown effects (e.g. sihnRNPA1 or 
siG3BP1). Remarkably, other proteins from the DDX5 family (DEAD box) have been shown to promote transla-
tion through their helicase activity41,42. In addition, siPARP1 decreases translation efficiency; however an indirect 
effect of PARylation inhibition cannot be ruled out because of the high amount of PARP1 substrates that take part 
in a variety of cell processes43. The detection of translation-related proteins in the pulled-down assays plus the 
described modulation of translation activity of HCV CRE-containing RNA constructs, suggests an association 
between the translational machinery and the CRE when the cellular scenario is suitable. Further, a group of nine 
proteins (with hnRNPs, RNA-binding Musashi homologues, RNA-binding proteins and DAZ-associated protein 
among them) have been classified as structural constituents of ribosomes (GO:0003735), and to belong to the 
structural molecule activity group (GO:0005198). This reinforces that CRE is able to interact with ribosome com-
ponents and modulate viral translation through association with host translation factors. Experiments designed 
to see whether this is the case are currently underway.
Finally, some proteins were selected to check whether they had any important involvement in HCV replication. 
In this work, replication experiments were performed on a hepatoma cell line containing a subgenomic HCV rep-
licon defective for the viral protease (NS2/NS3). As an advantage, these assays reproduce quite accurately the HCV 
genome replication, being a good biological model. On the other hand one cannot exclude additional interactions 
of the assayed proteins with other regions of the HCV genome contained in the replicon, more than the CRE ele-
ment. In fact some of the proteins tested for their implication in replication have been suggested to interact with 
other regions of the genome of the HCV (see references in table 1). Regarding the studied candidates, HMGB1 is an 
antiviral factor that changes its cell location and is secreted to the extracellular medium after HCV infection44. In 
agreement with a previous report showing that blocking of HMGB1 with specific antibodies increases HCV infec-
tivity44, the results derived from the knockdown and overexpression experiments suggest that HMGB1 negatively 
modulates HCV replication in the replicon system. On the other hand, in the present work no significant effect 
of G3BP1 on HCV replication was detected, although other authors report enhancing effects of G3BP1 on this 
process12,45,46. These discrepancies, however, could be due to differences in the replicon model used or the amount 
Figure 7. HCV IRES activity in Huh-7 cells treated with siRNAs. (A) Scheme of the ICU and Cap-RLuc RNA 
constructs. ICU is composed by HCV IRES, CRE and 3′ UTR regions flanking the reporter gene of the Firefly 
luciferase. cap-RLuc contains Renilla luciferase RNA, capped during in vitro transcription. (B) Huh-7 cells were 
treated with the indicated siRNAs and transfected with a mix containing 1 μ g FLuc-ICU and 0.25 μ g cap-RLuc 
per well. Luciferase activity was measured after 4 h and translation efficiency calculated as FLuc/RLuc activities. 
Standard deviation is displayed for each siRNA. Significant differences between siRNAs and non-targeting 
siRNA are indicated above the corresponding bar (p < 0.05 in a two-tailed Student’s t-test).
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or strategy of interference RNA employed. G3BP1 has been described to bind HCV RNA polymerase NS5B47 sug-
gesting that it possesses both RNA- and protein-interacting sites, and that it may be able to regulate replication. It 
should be noted that G3BP1 has been reported to associate with viral genome 3′ elements that regulate replication 
in Dengue virus, a member of the family Flaviviridae45. All this together suggests G3BP1 to be a cellular host factor 
that can be hijacked by the genome of RNA viruses, with a consequent effect on viral replication. Finally, a protein 
with high antireplicative activity was found: hnRNPA1. Here we report the direct association of hnRNPA1 to the 
HCV CRE by the pulldown and the immunoprecipitation experiments. This ribonucleoprotein has previously 
been reported to bind as well to the viral polymerase NS5B48. In the latter work, the binding of hnRNPA1 to the 
5′ and 3′ UTR (downstream of CRE) was also shown. Since CRE plays a role in both NS5B binding49 and in viral 
5′ -3′ contacts21,22, one might hypothesize that the binding of hnRNPA1 to CRE would have an effect on HCV rep-
lication. In the present work, hnRNPA1 clearly downregulates HCV replication, one explanation could be that this 
protein competes with NS5B for CRE binding, thus reducing the efficiency of the viral polymerase. However, due 
to the limitation of the replicon system, we cannot exclude the possibility of a partial effect of hnRNPA1 knock-
down on HCV replication by direct interaction with NS5B or even synergic effects of both actions. Additionally, 
hnRNPA1 has been reported to act as a splicing factor in the maturation of IFR3, which is involved in the interferon 
response50. The role of hnRNPA1 in HCV resistance to IFN response would certainly be interesting to explore.
In conclusion, the current work reports a number of new HCV RNA-host protein associations. Further work 
on these factors will be needed to better comprehend their function in the viral cycle.
Methods
DNA templates and RNA synthesis. DNA coding for the CRE transcript was obtained by PCR amplifica-
tion, ensuring the presence of the precise 3′ end. Briefly, T7pC + HV was amplified from plasmid pU3′ HCV9181 
using the primers T7pHCV-918133 and asHCV9414 (5′ -AACAGGATGGCCTATTGGCCTG-3′ ) to obtain the 
template for CRE plus the downstream hypervariable region (9181–9414). A shorter amplicon, CRE (9181–9384), 
was amplified using T7pHCV-9181 and as HCV9384 (AGCTCCCCGTTCATCGGTT) primers. The template 
for RNA 667 was derived from the pcDNA3 vector (Invitrogen) linearized with DraIII51. RNA synthesis was 
performed using the TranscriptAid T7 High Yield Kit (Thermo Fisher Scientific), following the manufacturer’s 
instructions. The resulting transcript was purified as previously described52. The RNA concentration was deter-
mined by UV spectrophotometry (A260) and the degree of protein and carbohydrate/phenolic contamination 
assessed from the A260/A280 and A260/A230 ratios respectively. The integrity of the RNA was confirmed by denatur-
ing agarose-formaldehyde gel electrophoresis.
RNA construct (ICU) containing a luciferase reporter gene flanked by the HCV genomic ends was obtained by 
amplification of pGLICU plasmid with 5′ pT7HCV and 3′ HCV primers22, in vitro transcription and purification 
as explained above. The generation of a capped RLuc RNA was generated as previously described51.
Cell culture. The cell lines used in this study were a gift from Dr. R. Aldabe (University of Navarra, Spain). 
The human hepatoma Huh-7 cells were maintained in Dulbecco’s modified Eagle medium (DMEM) supplemented 
with 10% heat-inactivated fetal bovine serum and 1 mM sodium pyruvate, at 37 °C in a 5% CO2 atmosphere. The 
knockdown assays were performed in the named cells and in a human hepatocarcinoma cell line harboring an HCV 
subgenomic replicon system (Huh-7 NS3-3′ )53,54. Replicon cells were maintained in DMEM supplemented with 20% 
heat-inactivated fetal bovine serum and 0.5 mg/ml G-418 under the same conditions as described for the Huh-7 cells.
Cell lysate preparation. S10 fractions of Huh-7 cell lysates for use in pull-down assays were essentially 
prepared as previously described55, with some modifications. Briefly, around 5 × 107 Huh-7 cells were grown 
as described above to reach 100% confluent monolayers. They were then treated with trypsin, washed with 10 
volumes of isotonic buffer (35 mM HEPES/KOH, pH 7.6, 150 mM NaCl and 11 mM glucose) and pelleted by 
centrifugation at 1,000 × g for 5 min. Cellular lysis was performed by adding 1.5 volumes of cold hypotonic buffer 
(20 mM HEPES/KOH, pH 7.6, 10 mM KCl, 1.5 mM MgAc, 1 mM DTT and protease inhibitors) and incubation at 
4 °C for 20 min. Cell lysate was homogenized in a glass Dounce homogenizer (25 strokes) and equilibrated with 
0.2 volumes of S10 buffer (100 mM HEPES/KOH pH 7.6, 0.6 M KAc, 20 mM MgAc, 25 mM DTT and protease 
inhibitors). Cellular debris was removed by centrifugation at 10,000 × g for 10 min. The resulting cleared lysates 
contained around 30 A280 units ml−1.
Isolation and identification of CRE-interacting proteins. Transcript C + HV (500 pmol) was 
annealed to 1 nmol of the 5′ biotinylated oligonucleotide (b-asHCV-9414) (Eurofins MWG Operon) or to the 
respective unlabeled asHCV-9414 for control reactions (sequence detailed in DNA template and RNA synthe-
sis). It was then incubated with Huh-7 S10 cell extracts (~10 mg of proteins) pretreated with 50 μ g of tRNA and 
CL buffer (100 mM HEPES pH 7.6, 50 mM KAc, 1 mM MgAc and 1 mM DTT). Reactions were performed at 
25 °C for 20 min to allow for CRE-protein interactions to take place. For the affinity chromatography step, 5 mg 
of streptavidin-coupled Dynabeads® (Invitrogen) were washed and equilibrated following the manufacturer’s 
instructions. Ribonucleoprotein complexes were captured by incubation of the Dynabeads in the binding reaction 
in a rotation wheel for 30 min at room temperature. Unbound factors were removed after washing three times 
with buffer B (0.1 M NaCl and 0.1% Tween® 20) pre-warmed at 37 °C. CRE-protein complexes were eluted from 
the beads by heating for 2 min at 95 °C in the presence of 95% formamide and 10 mM EDTA. The recovered poly-
peptides were precipitated in methanol/chloroform. Some 2/3 of the sample volume was aliquoted for LC-MS/MS 
analysis and the rest used in SDS-PAGE. For the latter, samples were resuspended in Laemmli buffer 1X (10 mM 
Tris-HCl pH 6.8, 5% SDS, 2 mM EDTA, 5% Glycerol, 1% β -mercaptoethanol, 0.1 mg/ml Bromophenol blue) and 
loaded onto a polyacrylamide gel (5% stacking, 12% resolving). Proteins were stained by Sypro-Ruby (BioRad) 
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and scanned in a Typhoon 9400 scanner (GE Healthcare). Both biotinylated and non-biotinylated reactions were 
conducted in duplicate (biological samples = 4).
Mass spectrometry analysis. The rest of the samples were resuspended, digested and run in LC-MS/MS 
following a protocol similar to that used by others56,57 with minor modifications58. The specifics of this protocol 
are depicted in Supplementary Note S1. Each replicate was run twice, independently (two technical replicates 
per sample). Protein enrichment was established by PEAKS 6 software as protein ratio ≥1.00:0.50 in biotinylated 
samples versus the controls. Only proteins with > 15% coverage in positive samples (biotinylated) were finally 
selected. The number of recovered peptides, coverage and ratios of positive samples were calculated as average 
of the four corresponding technical replicates. The list of the proteins enriched for each comparison is shown in 
Supplementary Table 1.
Bioinformatics resources. The Panther gene list analysis tool was used to classify the pulled-down pro-
teins59. The list for analysis included the Uniprot IDs shown in Table 1 (or analogue IDs in the very few necessary 
cases). Proteins were classified in gene ontology (GO) terms related to “molecular function”, and their proportions 
represented in a pie chart. Successive classification was performed for the two most represented groups.
The same protein list was examined using the Database for Annotation, Visualization and Integrated 
Discovery (DAVID) v6.7 bioinformatics resources (http://david.abcc.ncifcrf.gov/home.jsp). Functional annota-
tion clustering of the protein list was performed under the highest classification stringency. A total of 13 anno-
tation categories were selected (by default) for the search. As indicated by Huang and co-workers27, only clusters 
with an enrichment score of ≥ 1.3 and a p value of < 0.05 were taken into account for further analysis.
The catRAPID webserver was used for predicting RNA-protein interaction (http://service.tartaglialab.com/
page/catrapid_group). The CRE sequence was run against the Homo sapiens nucleotide-binding proteome using 
the catRAPID omics tool. A search was performed for RNA- or DNA-binding full-length proteins. Proteins were 
ordered based on their Rating Star Score, which considers the protein-RNA Interaction Propensity score (i.e. the 
interaction probability) and the presence of RNA/DNA binding domains and motifs. Additionally, nine different 
FASTA protein sequences, taken from the Uniprot database, were run (using the catRAPID graphic tool) against 
the complete CRE sequence, and nucleotide-aminoacid interaction heat-maps obtained.
Protein knockdown mediated by RNA interference and subgenomic HCV RNA quantification. 
Huh-7 NS3-3′ cells were cultured (300,000 cells/well) in 6 well-plates to obtain a confluence of at least 80% after 
24 h. Cells harbouring a subgenomic HCV replicon were transfected with small interference RNAs (siRNAs) 
designed against the mRNAs of the proteins of interest. For hnRNPA1, DDX5, G3BP1 and HMGB1, a pool of four 
targeting siRNAs for each protein was designed (Dharmacon). For PARP1 inhibition, a specific siRNA (Sigma) 
was used. As a negative control, a single non-targeting (NT) siRNA (Dharmacon) was selected. siRNAs were 
mixed with TransfectinTM solution in Opti-MEM® medium. The transfection mixture was added to the Huh-7 
NS3-3′ cells in an antibiotic-deprived medium to achieve a final siRNA concentration of 50 nM. After 48 h, the 
cells were collected for RNA or protein extraction.
RNA extraction was performed using Trizol reagent54. Primer extension was achieved using the High Capacity 
cDNA Reverse Transcription Kit (Thermo Fisher Scientific). Briefly, RNA extracted (40 ng) was annealed to ran-
dom primers in a 10 μ l volume reaction, at 95 °C for 2 min, and at 16 °C for 15 min. cDNA was retrotranscribed 
in a total volumen of 20 μ l at 37 °C for 30 min following manufacturer instructions. Enzyme inactivation was 
performed at 85 °C for 5 min. Intracellular HCV replicon RNA levels were measured as previously described and 
normalized with those obtained for the internal mRNA encoding GAPDH54. The HCV fragment was amplified 
by PCR over 40 cycles (5 s at 95 °C and 5 s at 58 °C) in a CFX96 Thermal Cycler (BioRad).
For protein extraction, cells were scraped after adding 500 μ l of cold PBS, and centrifuged at 2500 rpm. The 
resulting pellet was resuspended in 200 μ l of protein Lysis Buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% 
Triton X-100, supplemented with protease inhibitor cocktail tablets) for 30 min at 4 °C. Lysates were centrifuged 
at 12,500 rpm and the supernatant stored at −20 °C. The protein concentration was measured using BioRad 
Protein Assay reagent. Proteins were separated by SDS-PAGE and transferred to nitrocellulose membranes in a 
SemiDry Trans Blot apparatus (BioRad). Membranes were blocked in 5% dry milk in TBS-Tween and incubated 
with specific primary antibodies against hnRNPA1, DDX5, HMGB1 (Cell Signaling Technology) G3BP1 (Santa 
Cruz Technology) or PARP1 (a gift from Dr. Oliver, Institute of Parasitology and Biomedicine López-Neyra, 
Granada, Spain) in 1% BSA-TBS/Tween solution at 4 °C overnight. Secondary HRP-linked antibodies were added 
for 1 h. Chemiluminescence was then detected using the ClarityTM Western ECL Substrate Kit (BioRad).
Overexpression of hnRNPA1 and HMGB1 coding genes. Total RNA from Huh-7 cells 
was extracted using Trizol reagent. Primer extension was performed as described above using 
instead an oligodT and annealing at 25 °C. cDNA was amplified by PCR using 5′ HMGB1-EcoRI 
(GCGTATGAATTCATGGGCAAAGGAGATCCTAAGAA) and asHMGB1 (GCGTATCTCGAGTTCA 
TCATCATCATCTTCTTCT) primers for HMGB1 and 5 ′  A1 (GCGTATGGATCCATGTCTAA 
GTCAGAGTCTCCTAAA) and asA1 (GCGTATCTCGAGTTAAAATCTTCTGCCACTGCCATA) for 
hnRNPA1. PCR amplicons were digested with EcoRI and XhoI for HMGB1 sequence and BamHI and XhoI for 
hnRNPA1 and inserted in pcDNA3 vector digested with the corresponding enzymes. Plasmid isolation was 
perfomed using Qiagen® Plasmid Maxi Kit (Qiagen). Huh-7 NS3-3′ cells were cultured in 6 well plates and 
allowed to grow up to 80% confluence, then cells were transfected with 2 μ g/well of pcDNA3 (as a control) or 
pcDNA3-hnRNPA1 or pcDNA3-HMGB1, and total RNA was extracted 24 h or 48 h after transfection using 
Trizol reagent. Quantification of HCV RNA levels was performed by RT-qPCR as described above. Relative 
amounts of hnRNPA1 and HMGB1 mRNAs to GAPDH mRNA in the total RNA mix was analyzed by RT-PCR 
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amplification with the following primers: 5′ A1-2D (GCGTATGGATCCTCCAGCCAAAGAGGTCGAAGT) and 
asA1 for hnRNPA1; asHMGB1-A (GCGTATCTCGAGGAACTTCTTTTTTGTCTCCCCTT) and 5′ HMGB1 for 
HMGB1. Amplification products were resolved in a 2% agarose gel.
RNA-immunoprecipitation (RIP). The RIP assay was carried out following the protocol described by 
Niranjanakumari and coworkers60. Briefly, Huh-7 cells at 80–90% confluence were transfected with same amount 
(85 pmol) of CRE (9181–9384) or RNA 667. After 4 h cells were trypsinized, collected in PBS and crosslinked with 
5% formaldehyde for 10 min. Quenching with 250 mM Glycine for 5 min was done and cells were washed, pel-
leted by centrifugation and frozen down at −80 °C. Cells were resuspended (an aliquot stored at −20 °C) in RIPA 
buffer (50 mM TRIS-HCl, 1% NP-40, 0.5% Sodium deoxycholate, 0.05% SDS, 1 mM EDTA, 150 mM NaCl, and 
protease inhibitors), sonicated and precleared with Protein A Dynabeads (Cell Signaling Technology) in the pres-
ence of 25 μ g of tRNA per reaction. Precleared lysates were recovered and exposed to new Protein A Dynabeads 
previously linked to the anti-hNRNPA1 antibody (which is compatible with immunoprecipitation). Binding was 
performed for 90 min in rotation and beads were extensively washed (6 times) with high-stringency RIPA buffer 
(50 mM TRIS-HCl, 1% NP-40, 1% Sodium deoxycholate, 0.1% SDS, 1 mM EDTA, 1 M NaCl, 2 M Urea and 0.2% 
PMSF). Crosslink was reverted by beads resuspension in 50 mM Tris-HCl, 5 mM EDTA, 10 mM DTT and 1% 
SDS and heating at 70 °C for 45 min, conducting in parallel an aliquot of the lysates. RNA was extracted and retro-
transcribed using the specific primers asHCV9359 (TAGATAGATGCCTACCCCTACAGA) and RNA667-REV 
(TATTGTCTTCCCAATCCTCCC) for the CRE and RNA 667 respectively. cDNA was precipitated in ethanol 
and amplified by PCR using primers HCV9181 (GGGCAGTAAGGACCAAGCTCAAA) and asHCV9359 for 
CRE and RNA667-FW (CTCGACTGTGCCTTCTAGTT) and RNA667-REV for RNA 667. Lysates and RNA 
templates (30 fmol) were subjected to RT-PCR in parallel. Samples were resolved in a 2% agarose gel.
Luciferase measurement in HCV CRE-containing RNA constructs. Huh-7 cells were seeded in 
24-well plates and allowed to grow until reach 80% confluence. Cells were transfected with siRNAs against the 
mRNAs of selected proteins as indicated above. After 48 h cells were re-transfected with RNA constructs contain-
ing Firefly or Renilla luciferase reporter genes and translation efficiency measured after 4 h using Dual Luciferase 
Reported Assay System (Promega). Translation efficiency was determined by the ratio FLuc/RLuc (Firefly lucif-
erase /Renilla luciferase.
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